Anaemia in pregnancy: prevalence and treatment response to various modalities: a prospective study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20203857Keywords:
Anaemia, β thalassemia trait, Intravenous iron therapy, Oral iron therapy, PregnancyAbstract
Background: Anaemia seen in pregnancy are largely preventable and easily treatable if detected in time, despite this, anaemia still continues to be a common cause of maternal and perinatal morbidity and mortality in India.
Methods: A prospective observational study of 200 pregnant women with anaemia was carried out from Jun 2017 to December 2018 at a Tertiary care hospital with pan India population. Patients underwent clinical examination and laboratory tests to find out the severity and type of anaemia and were treated accordingly. Iron deficiency anaemia was treated with oral or intravenous iron therapy depending upon the hemoglobin concentration. Patients were followed up after 28 days of treatment and hemoglobin estimation was done to monitor the treatment response.
Results: A total 36.49% pregnant women had hemoglobin less than 10 gm%. 151 out of 200 women had serum ferritin <12 ng/ml which indicates that iron deficiency anaemia is the commonest type of anaemia in pregnancy. Overall, out of 200 patients 5.5% patients were found to have hemoglobinopathies (β thalassemia trait). After 28 days of treatment mean increase in hemoglobin was 2.40 gm% and 4.24 gm% in patients receiving oral and intravenous iron therapy respectively.
Conclusions: A total 36.49% pregnant women were found to have anaemia during pregnancy and iron deficiency anaemia is the commonest type of anaemia. Therefore, there is still a need for dietary counselling and health education in the community. 5.5% patients were found to have beta thalassemia trait which was detected only after conducting hemoglobin electrophoresis. Both oral and intravenous iron therapy are effective in treatment of iron deficiency anaemia but intravenous iron therapy results in a more rapid resolution of anaemia.
References
World Health Organization. Nutritional anaemias. World Health Organ Tech Rep Ser; 1972:503.
WHO/CDC. Worldwide prevalence of anaemia 1993-2005. WHO global database on anaemia. Geneva, World Health Organization; 2008.
Stevens G, Finucane M, De-Regil L, Paciorek C, Flaxman S, Branca F, et al. Global, regional, and national trends in total and severe anaemia prevalence in children and pregnant and non-pregnant women. Lancet Global Health. 2013;1(1):16-25.
General R. Sample registration system maternal mortality in India: 1997-2003 trends, causes and risk factors. New Delhi: registrar general and centre for global health research university of Toronto. 2006.
Okeke PU. Anaemia in pregnancy-is it a persisting public health problem in porto novo-cape verde. Res J Med Sci. 2011;5:193-9.
Prema K, Neela Kumari S, Ramalakshmi BA. Anaemia and adverse obstetric outcome. Nutr Rep Int. 1981;23:637-43.
Lister VG, Rossiter CE, Chong M. Perinatal mortality. Br J Obstet Gyn. 1985;92 (Suppl 5):88-99.
Adamson JW. Iron deficiency and other hypoproliferative anemias. In: Braunwald E, Fauci AS, Kasper DL. Harrison‘s textbook of internal medicine, 17th ed. New York: McGraw Hill; 2008:628-633
Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial. J Obstet Gynaecol Res. 2013;39(2):504-10.
Gupta K, Arnold F, Kishor S, Parasuraman S. Concern on prevalence of anaemia in pregnant and lactating women in India. Indian J Med Res. 2007:125.
Breymann C. Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy Euro J Obstet Gynecol Reprodu Biol. 2005;123 (Supl 2):3-13.
Toteja GS, Singh P, Dhillon BS. Prevalence of anemia among pregnant women and adolescent girls in 16 districts of India. Food Nutrit Bullet. 2006;27(4):311-5.
Vijaynath J, Ramesh P. Prevalence of anemia in pregnancy. Ind J Applied Basic Med Sci. 2010;12:23-35.
Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. Ind J Applied Basic Med Sci. 2013;138(1):78.
Saraswathi KS, Aljabri F, Shyamala R. Prevalence of anaemia among antenatal women in a tertiary care hospital, South India. Der Pharmacia Lettre. 2013;5(1):146-8.
Sharma JB, Jain S, Mallika V. A prospective, partially randomized study of pregnancy outcomes and hematologic responses to oral and intramuscular iron treatment in moderately anemic pregnant women, Am J Clin Nutr. 2004;79:116-22.
Varawalla NY, Old JM, Sarkar R, Venkatesan R, Weatherall DJ. The spectrum of beta thalassemia mutations on the Indian subcontinent the basis of prenatal diagnosis. Brit J Hematol. 1991;78:242-7.
Bobhate SK. NESTROFT as a screening test for detection of β-thalassemia trait. Indian J Pathol Microbiol. 2002;45(3):265-7.
Madan N, Sharma S, Sood SK, Colah R, Bhatia HM. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16:16-25.
Reveiz L, Gyte GM, Cuervo LG. Treatments for iron-deficiency anaemia in pregnancy (cochrane review). The Cochrane Collaboration. 2007:2.
Al RA, Unlubilgin E, Kandemir O, Yalvac S, Cakir L, Haberal A. Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial. Obstet Gynecol. 2005;106:1335-40.
Perewusnyk G, Huch R, Huch A, Breymann C. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. Br J Nutr. 2002;88:3-1.
